Helena Levander

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
16 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Helena Levander's trades of Cinclus Pharma Holding publ AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-20 2024-06-20
B Purchase
98,134
214.69
SEK4,371,514 		98,134 214.69 SEK4,371,514
2024-06-20 2024-06-20
B Purchase
1,413
12.54
SEK2,748,354 		1,413 12.54 SEK2,748,354
2024-06-20 2024-06-20
B Purchase
99,055
13.20
SEK1,084,700 		99,055 13.20 SEK1,084,700
2024-06-20 2024-06-20
B Purchase
2,000
36.40
SEK72,800 		2,000 36.40 SEK72,800
2024-06-20 2024-06-20
B Purchase
1,490
42.00
SEK62,580 		1,490 42.00 SEK62,580
2024-06-20 2024-06-20
B Purchase
2,000
36.40
SEK72,800 		2,000 36.40 SEK72,800
2022-02-23 2022-02-22
B Purchase
3,000
120.20
SEK360,600 		3,000 120.20 SEK360,600
2021-12-16 2021-12-16
B Purchase
3,000
132.00
SEK396,000 		3,000 132.00 SEK396,000
2021-03-05 2021-03-05
SE Medivir AB (MVIR-B)
B Purchase
24,390
8.50
SEK207,315 		24,390 8.50 SEK207,315
2021-03-05 2021-03-04
SE Medivir AB (MVIR-B)
B Purchase
17,868
8.50
SEK151,878 		17,868 8.50 SEK151,878
2021-03-05 2021-03-03
SE Medivir AB (MVIR-B)
B Purchase
242
8.50
SEK2,057 		242 8.50 SEK2,057
2021-02-16 2021-02-15
SE Recipharm AB (RECI-B)
S Sale
4,200
232.00
SEK974,400 		4,200 232.00 SEK974,400
2021-02-10 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
50,000
7.00
SEK350,000 		50,000 7.00 SEK350,000
2021-02-03 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
50,000
7.00
SEK350,000 		50,000 7.00 SEK350,000
2020-06-25 2020-06-22
B Purchase
1,200
70.00
SEK84,000 		1,200 70.00 SEK84,000
2020-06-22 2020-06-22
B Purchase
1,200
70.00
SEK84,000 		1,200 70.00 SEK84,000
2020-03-19 2020-03-18
B Purchase
1,000
76.00
SEK76,000 		1,000 76.00 SEK76,000
2020-03-19 2020-03-18
B Purchase
1,000
75.60
SEK75,600 		1,000 75.60 SEK75,600
2019-12-17 2019-12-17
SE Medivir AB (MVIR-B)
B Purchase
3,500
11.34
SEK39,690 		3,500 11.34 SEK39,690
2019-12-17 2019-12-17
SE Medivir AB (MVIR-B)
B Purchase
20,000
11.20
SEK224,000 		20,000 11.20 SEK224,000
2019-04-01 2019-04-01
SE Medivir AB (MVIR-B)
B Purchase
3,000
16.00
SEK48,000 		3,000 16.00 SEK48,000
2019-04-01 2019-04-01
SE Medivir AB (MVIR-B)
B Purchase
2,000
15.90
SEK31,800 		2,000 15.90 SEK31,800
2019-03-29 2019-03-28
SE Medivir AB (MVIR-B)
B Purchase
10,000
16.49
SEK164,900 		10,000 16.49 SEK164,900
2019-03-29 2019-03-27
SE Medivir AB (MVIR-B)
B Purchase
10,000
16.70
SEK167,000 		10,000 16.70 SEK167,000
2017-12-01 2017-11-30
SE Recipharm AB (RECI-B)
B Purchase
3,000
87.00
SEK261,000 		3,000 87.00 SEK261,000